TY  - JOUR
A1  - Brodehl, Andreas
A1  - Gerull, Brenda
T1  - Genetic insights into primary restrictive cardiomyopathy
JF  - Journal of Clinical Medicine
N2  - Restrictive cardiomyopathy is a rare cardiac disease causing severe diastolic dysfunction, ventricular stiffness and dilated atria. In consequence, it induces heart failure often with preserved ejection fraction and is associated with a high mortality. Since it is a poor clinical prognosis, patients with restrictive cardiomyopathy frequently require heart transplantation. Genetic as well as non-genetic factors contribute to restrictive cardiomyopathy and a significant portion of cases are of unknown etiology. However, the genetic forms of restrictive cardiomyopathy and the involved molecular pathomechanisms are only partially understood. In this review, we summarize the current knowledge about primary genetic restrictive cardiomyopathy and describe its genetic landscape, which might be of interest for geneticists as well as for cardiologists.
KW  - restrictive cardiomyopathy
KW  - cardiomyopathy
KW  - cardiovascular genetics
KW  - desmin
KW  - troponin
KW  - filamin-C
Y1  - 2022
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-270621
SN  - 2077-0383
VL  - 11
IS  - 8
ER  - 
TY  - JOUR
A1  - Brodehl, Andreas
A1  - Milting, Hendrik
A1  - Gerull, Brenda
T1  - Special Issue “Cardiovascular Genetics”
JF  - Genes
N2  - No abstract available
KW  - cardiovascular genetics
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234229
SN  - 2073-4425
VL  - 12
IS  - 4
ER  - 
TY  - JOUR
A1  - Gerull, Brenda
A1  - Brodehl, Andreas
T1  - Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy
JF  - Current Heart Failure Reports
N2  - Purpose of Review
Arrhythmogenic cardiomyopathy (ACM) is a genetic disease characterized by life-threatening ventricular arrhythmias and sudden cardiac death (SCD) in apparently healthy young adults. Mutations in genes encoding for cellular junctions can be found in about half of the patients. However, disease onset and severity, risk of arrhythmias, and outcome are highly variable and drug-targeted treatment is currently unavailable.
Recent Findings
This review focuses on advances in clinical risk stratification, genetic etiology, and pathophysiological concepts. The desmosome is the central part of the disease, but other intercalated disc and associated structural proteins not only broaden the genetic spectrum but also provide novel molecular and cellular insights into the pathogenesis of ACM. Signaling pathways and the role of inflammation will be discussed and targets for novel therapeutic approaches outlined. 
Summary
Genetic discoveries and experimental-driven preclinical research contributed significantly to the understanding of ACM towards mutation- and pathway-specific personalized medicine.
KW  - dilated cardiomyopathy
KW  - arrhythmogenic cardiomyopathy
KW  - junctions
KW  - sudden cardiac death
KW  - cardiovascular genetics
KW  - desmosomes
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-269916
SN  - 1546-9549
VL  - 18
IS  - 6
ER  - 
TY  - JOUR
A1  - Brodehl, Andreas
A1  - Pour Hakimi, Seyed Ahmad
A1  - Stanasiuk, Caroline
A1  - Ratnavadivel, Sandra
A1  - Hendig, Doris
A1  - Gaertner, Anna
A1  - Gerull, Brenda
A1  - Gummert, Jan
A1  - Paluszkiewicz, Lech
A1  - Milting, Hendrik
T1  - Restrictive cardiomyopathy is caused by a novel homozygous desmin (DES) mutation p.Y122H leading to a severe filament assembly defect
JF  - Genes
N2  - Here, we present a small Iranian family, where the index patient received a diagnosis of restrictive cardiomyopathy (RCM) in combination with atrioventricular (AV) block. Genetic analysis revealed a novel homozygous missense mutation in the DES gene (c.364T > C; p.Y122H), which is absent in human population databases. The mutation is localized in the highly conserved coil-1 desmin subdomain. In silico, prediction tools indicate a deleterious effect of the desmin (DES) mutation p.Y122H. Consequently, we generated an expression plasmid encoding the mutant and wildtype desmin formed, and analyzed the filament formation in vitro in cardiomyocytes derived from induced pluripotent stem cells and HT-1080 cells. Confocal microscopy revealed a severe filament assembly defect of mutant desmin supporting the pathogenicity of the DES mutation, p.Y122H, whereas the wildtype desmin formed regular intermediate filaments. According to the guidelines of the American College of Medical Genetics and Genomics, we classified this mutation, therefore, as a novel pathogenic mutation. Our report could point to a recessive inheritance of the DES mutation, p.Y122H, which is important for the genetic counseling of similar families with restrictive cardiomyopathy caused by DES mutations.
KW  - cardiovascular genetics
KW  - restrictive cardiomyopathy
KW  - desmin
KW  - intermediate filaments
KW  - desmin-related myopathy
KW  - cardiomyopathy
KW  - desminopathy
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-193121
SN  - 2073-4425
VL  - 10
IS  - 11
ER  -